Blue Earth Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$76.5M

Blue Earth Therapeutics develops clinical-stage PSMA-targeted radioligand therapies for improving prostate cancer treatment outcomes.